Moleculin Biotech, Inc. (MBRX) has 6 SEC Form 4 insider filings on record in the last 90 days. That includes 3 insider purchases totalling $0. Most recent filing: Aug. 5, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 5, 2026 filed Aug. 3, 2026 | Foster Jonathan P. Chief Financial Officer | $0 | 1,173,332 | +40% | No | |
|
|
||||||
| Aug. 5, 2026 filed Aug. 3, 2026 | KLEMP WALTER V CEO and President | $0 | 2,133,332 | +38% | No | |
|
|
||||||
| Aug. 5, 2026 filed Aug. 3, 2026 | PICKER DONALD H Chief Science Officer | $0 | 693,332 | +47% | No | |
|
|
||||||
| June 24, 2026 filed June 20, 2026 | PICKER DONALD H Chief Science Officer | — | +81 | +0% | No | |
|
|
||||||
| June 24, 2026 filed June 20, 2026 | KLEMP WALTER V CEO and President | — | +385 | +0% | No | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free